Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Post-streptococcal glomerulonephritis epidemiology and demographics
Introduction
Overview
Overview
The incidence of post-streptococcal glomerulonephritis is approximately 9.5 to 28.5 per 100,000 individuals worldwide. The case-fatality rate of post-streptococcal glomerulonephritis is approximately 2 percent in India and 0.08 percent in Turkey. It commonly affects children with age between 5 to 12 years. The incidence of post-streptococcal glomerulonephritis increases in older people age greater than 60 years. It commonly affects children with age between 5 to 12 years. Men are more commonly affected by post-streptococcal glomerulonephritis than women. The majority of post-streptococcal glomerulonephritis cases are reported in developing countries.
Epidemiology and Demographics
Epidemiology and Demographics
Incidence
- The incidence of post-streptococcal glomerulonephritis is approximately 9.5 to 28.5 per 100,000 individuals worldwide.[1]
Case-fatality rate
- The case-fatality rate of post-streptococcal glomerulonephritis is approximately 2 percent in India and 0.08 percent in Turkey.[2]
Age
- The incidence of post-streptococcal glomerulonephritis increases in older people age greater than 60 years.
- It commonly affects children with age between 5 to 12 years.
Race
- There is no racial predilection to post-streptococcal glomerulonephritis.
Gender
- Men are more commonly affected by post-streptococcal glomerulonephritis than women.
Region
- The majority of post-streptococcal glomerulonephritis cases are reported in developing countries.[3]
References
References
- ↑ Carapetis JR, Steer AC, Mulholland EK, Weber M (November 2005). “The global burden of group A streptococcal diseases”. Lancet Infect Dis. 5 (11): 685–94. doi:10.1016/S1473-3099(05)70267-X. PMID 16253886.
- ↑ Jackson SJ, Steer AC, Campbell H (January 2011). “Systematic Review: Estimation of global burden of non-suppurative sequelae of upper respiratory tract infection: rheumatic fever and post-streptococcal glomerulonephritis”. Trop. Med. Int. Health. 16 (1): 2–11. doi:10.1111/j.1365-3156.2010.02670.x. PMID 21371205.
- ↑ Rodriguez-Iturbe B, Musser JM (October 2008). “The current state of poststreptococcal glomerulonephritis”. J. Am. Soc. Nephrol. 19 (10): 1855–64. doi:10.1681/ASN.2008010092. PMID 18667731.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2]